Peripheral Artery Stent Market is witnessing robust expansion as the global burden of peripheral artery disease (PAD) continues to rise alongside advancements in interventional cardiology and vascular surgery. According to the latest Peripheral Artery Stent Market Regional Analysis, Demand Analysis and Competitive Outlook 2025–2032 report, the market was valued at USD 1.74 billion in 2024 and is projected to reach USD 4.09 billion by 2031, registering a compound annual growth rate (CAGR) of 13.3% during the forecast period.
Preview Market Insights with a Free Sample Report https://www.24lifesciences.com/download-sample/5694/peripheral-artery-stent-market-market
Peripheral artery stents play a critical role in restoring blood flow in narrowed or blocked peripheral arteries, particularly in the lower extremities. The market’s growth underscores its increasing importance within the healthcare and life sciences ecosystem, supported by rising cardiovascular risk factors, aging populations, and expanding access to minimally invasive treatment options across developed and emerging economies.
Market Highlights: Segmentation and Growth Drivers
By Type: Drug-Eluting Stents Lead Clinical Adoption
The peripheral artery stent market is segmented into self-expanding stents, balloon-expandable stents, drug-eluting stents, and bare metal stents. Among these, drug-eluting stents continue to dominate the type segment. Their sustained drug-release mechanism significantly reduces restenosis rates and improves long-term vessel patency compared to bare metal alternatives. These superior clinical outcomes have positioned drug-eluting stents as the preferred choice in interventional radiology and vascular surgery units worldwide.
By Application: Hospitals Remain the Primary Treatment Setting
By application, the market includes hospitals, cardiac centers, vascular clinics, and ambulatory surgical centers. Hospitals account for the largest share, driven by their ability to manage complex PAD cases that require advanced imaging, multidisciplinary vascular teams, and emergency intervention capabilities. Hospitals also function as referral hubs for smaller facilities, reinforcing their central role in peripheral artery stent procedures.
By End User: Private Hospitals Drive Technology Adoption
The market is further segmented into public hospitals, private hospitals, and specialty clinics. Private hospitals show strong adoption, particularly in developed markets, due to their focus on advanced interventional radiology and cardiovascular services. These institutions invest heavily in next-generation stent technologies, physician training programs, and data-driven outcome monitoring, supporting continuous improvements in stent deployment and post-operative care.
Unlock Comprehensive Market Analysis Here https://www.24lifesciences.com/peripheral-artery-stent-market-market-5694
Emerging Trends Shaping the Healthcare Market
Emerging Trends Shaping the Healthcare Market The peripheral artery stent market is increasingly influenced by broader healthcare and life sciences trends, including the integration of advanced imaging technologies, data-driven clinical decision-making, and precision medicine approaches. Improvements in stent materials, drug-coating technologies, and delivery systems are enhancing procedural safety and long-term outcomes. Additionally, sustainability considerations and value-based healthcare models are encouraging manufacturers to focus on durable, cost-effective solutions that reduce repeat interventions. These innovations are expected to further accelerate market growth through the forecast period.
Regional Analysis: Global Demand with Strong Growth in Asia-Pacific
North America
North America holds a significant share of the peripheral artery stent market, supported by high PAD prevalence, well-established reimbursement frameworks, and rapid adoption of innovative stent technologies. Strong clinical research activity and the presence of leading market players further reinforce regional dominance.
Europe
Europe represents a mature yet steadily growing market, driven by aging populations and increasing awareness of early PAD diagnosis and treatment. Regulatory support for minimally invasive vascular procedures continues to encourage adoption across major European healthcare systems.
Asia-Pacific
The Asia-Pacific region is expected to witness the fastest growth during the forecast period. Rising cardiovascular disease incidence, expanding healthcare infrastructure, and improving access to interventional procedures in countries such as China, India, and Japan are fueling demand for peripheral artery stents.
Rest of the World
Other regions, including Latin America and the Middle East & Africa, are experiencing gradual growth supported by healthcare investments and increasing physician training in endovascular techniques.
Key Players and Competitive Landscape
The peripheral artery stent market competitive landscape is characterized by innovation, portfolio expansion, and geographical growth strategies.
- Medtronic plc leads the market with a broad portfolio of drug-eluting and bare-metal stents, supported by strong clinical evidence and long-standing physician relationships.
- Abbott Laboratories and Boston Scientific Corporation follow closely, offering advanced stent technologies designed for complex lesion anatomies with enhanced flexibility and drug delivery performance.
- BD Interventional and Terumo Corporation focus on expanding their presence in emerging markets, leveraging cost-efficient manufacturing and local partnerships.
- Cook Medical and Cordis Corporation emphasize R&D investments, particularly in next-generation and bioresorbable stent technologies aimed at reducing long-term complications and repeat procedures.
Key Peripheral Artery Stent Companies:
- Medtronic plc (Ireland)
- Abbott Laboratories (USA)
- Boston Scientific Corporation (USA)
- BD Interventional (USA)
- Terumo Corporation (Japan)
- Cook Medical (USA)
- Cordis Corporation (USA)
Unlock Comprehensive Market Analysis Here https://www.24lifesciences.com/peripheral-artery-stent-market-market-5694
Future Trends: Sustained Growth Through 2032
With a projected 13.3% CAGR, the peripheral artery stent market is set for sustained expansion through the forecast period. Rising PAD prevalence, continued technological innovation, and expanding access to minimally invasive vascular treatments will remain key growth drivers. As healthcare systems increasingly prioritize early intervention and long-term patient outcomes, the market is expected to present significant opportunities for manufacturers, healthcare providers, and investors alike.
Explore our related reports
About 24lifesciences
Founded in 2017, 24LifeScience has emerged as a trusted research and analytics partner for organizations operating within the global life sciences and chemical industries. Our core mission is to provide intelligent, future-ready insights that help clients stay ahead in an increasingly complex and innovation-driven market
International: +1(332) 2424 294 | Asia: +91 9425150513 (Asia)
Website: www.24lifesciences.com
Follow us on LinkedIn: www.linkedin.com/company/lifesciences24
- Single-Domain Heavy Chain Antibody Market - 2026-01-23
- Qianlie Antong Capsules Market - 2026-01-23
- Veterinary Amitraz Solution Market - 2026-01-23